Organon & Co (OGN)
18.71
+0.19
(+1.03%)
USD |
NYSE |
Apr 24, 16:00
18.59
-0.12
(-0.64%)
After-Hours: 20:00
Organon Debt to Equity Ratio: -125.14 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -125.14 |
| September 30, 2023 | -14.69 |
| June 30, 2023 | -15.73 |
| March 31, 2023 | -11.82 |
| December 31, 2022 | -9.992 |
| September 30, 2022 | -8.160 |
| June 30, 2022 | -7.822 |
| Date | Value |
|---|---|
| March 31, 2022 | -7.275 |
| December 31, 2021 | -6.057 |
| September 30, 2021 | -5.747 |
| June 30, 2021 | -4.834 |
| March 31, 2021 | 0.3219 |
| December 31, 2020 | 0.2441 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-125.14
Minimum
Dec 2023
0.3219
Maximum
Mar 2021
-16.67
Average
-7.822
Median
Jun 2022
Debt to Equity Ratio Benchmarks
| Merck & Co Inc | 0.9328 |
| Alnylam Pharmaceuticals Inc | -4.626 |
| Amgen Inc | 10.37 |
| Biogen Inc | 0.4688 |
| Pacira BioSciences Inc | 0.6004 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 12.06B |
| Total Liabilities (Quarterly) | 12.13B |
| Shareholders Equity (Quarterly) | -70.00M |
| Current Ratio | 1.545 |
| Net Debt Paydown Yield | -0.33% |